Mitumomab (BEC-2) is a mouse anti-BEC-2 monoclonal antibody investigated for the treatment of small cell lung carcinoma in combination with BCG vaccination...
3 KB (277 words) - 23:52, 14 June 2023
soravtansine Elahere mab chimeric folate receptor alpha Y ovarian cancer Mitumomab mab mouse GD3 ganglioside small cell lung carcinoma Modotuximab mab chimeric...
136 KB (4,020 words) - 07:14, 15 August 2024
Detumomab Edrecolomab Ibritumomab tiuxetan Igovomab Lilotomab Minretumomab Mitumomab Nacolomab tafenatox Moxetumomab pasudotox Naptumomab estafenatox Oregovomab...
5 KB (368 words) - 15:29, 21 August 2024
mitoxantrone (INN) mitozolomide (INN) Mitozytrex (Supergen) mitratapide (USAN) mitumomab (INN) mitumprotimut-T (USAN) Mivacron mivacurium chloride (INN) mivazerol...
9 KB (425 words) - 22:18, 23 March 2024
Detumomab Edrecolomab Ibritumomab tiuxetan Igovomab Lilotomab Minretumomab Mitumomab Nacolomab tafenatox Moxetumomab pasudotox Naptumomab estafenatox Oregovomab...
4 KB (241 words) - 13:42, 14 July 2024
Detumomab Edrecolomab Ibritumomab tiuxetan Igovomab Lilotomab Minretumomab Mitumomab Nacolomab tafenatox Moxetumomab pasudotox Naptumomab estafenatox Oregovomab...
3 KB (129 words) - 01:04, 19 July 2023